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Abstract. Separation anxiety is one of the most common behaviour problems of companion dogs. 
Ignoring the problem or an inadequate treatment can lead to abandonment, relinquishment to an animal 
shelter, or even euthanasia of affected dogs. A successful treatment is based on a management plan that 
improves the relationship between the owner and the dog, with behaviour therapy, and provides 
appropriate medication.  Our purpose was to evaluate the efficacy of Reconcile (Fluoxetine 
hydrochloride) in treatment of separation anxiety. For establishing the correct diagnosis were used 
anamnesis questionnaires, clinical and semiological methods and also paraclinical test. The results of this 
study demonstrate the clinical efficacy of Reconcile combined with behavioural therapy, for the treatment 
of separation anxiety in dogs.  
 




For the first domesticated dog and to this days relationship between man and dog 
developed so much that we can find the dog involved in all aspects of human life.  
During this transformation the dog was assigned different roles from hunting dog, guard 
dog, fighting, etc., but of all the most complex and complicated role is being a pet. In this sense 
the dog should adapt him self to the conditions that man gives him, to understand his master at 
any time and in any event, to obey him and to express his own personality only when the owner 
is available. All these challenges require great mental strength of their subject animal.  
The first contact that the puppy has in is with his mother to which he develops, in the 
transition period the attachment. This attachment relation is indispensable for the development and 
the socialization that is about to happen in dog's life (Pageat, 2006). But detaching of the mother is 
very important for understanding the hierarchical roles and owner attach. 
Sometimes it is possible for the dog to remain in the firs attachment stages so it will 
entirely depend on his attach figure, suffer of social infantilism. Canine separation anxiety occurs 
when a dog is separated from or denied access to figure (Simpson, 2007) even for short moments. 
Separation anxiety in dogs is one of the most frequent behaviour problems, affecting almost 14% 
of the dogs (Rice, 2001). In the classification of behavioural disorders separation anxiety is 
situated on the second place, after the aggression (Bamberger, 2006, Landesberg, 2003, 
Takeuchi, 2000). Because of its frequency and severity at the first sign or client complaint, 
veterinarians should initiate treatment (Asztalos et al., 2011). 
Fluoxetine, a selective serotonin reuptake inhibitor widely used in human medicine has 
proven efficacy in treating anxiety disorders in people (Clark, 2005, Murphy, 2000, Sonawalla, 
2002), so this drug was used as a clinical and experimental treatment of anxiety separation in 
dogs too (Beaver, 1999, Landesberg, 2008, Overall, 2001). 
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The purpose of this study was to assess the efficacy and tolerability of Reconcile (a product 
that is not used in Romania, but it is special made for the treatment of separation anxiety in dogs) 
comparing with Prozac (human use) for the treatment of anxiety separation in dogs.  
 
MATHERIALS AND METHODS 
 
We used a serotonin reuptake inhibitors (SSRI) treatment based on Fluoxetine 
hydrochloride: Reconcile and Prozac. Reconcile are chewable tablets specially made for 
separation anxiety treatments in dogs. Dose of Reconcile and Prozac was of 1-2 mg/kc/day.  
The observations were made on a group of 20 dogs from different races, ages and gender 
that presented signs of anxiety separation. To differentiate a diagnosis we first used clinical and 
paraclinical test and some semiological methods. For an accurate diagnostic we used observation, 
complete anamnesis questionnaires and some evaluation sheets. The results we obtained were 
used to classify the patients. Because in separation anxiety the most obvious behavioral signs 
include intensive destructiveness, vocalization, elimination, anorexia, salivation, attepts of 
escape, behavioral depresion ant the most frequent modification appears in temperature, 
respiration and pulse, then on the cortisol, calcium and magnesium levels our purpose was to 
determine the effects of Reconcile treatment on these indicators  
 
RESULTS AND DISCUTIONS 
 
Separation anxiety is caused by an over attachment of the dog by his primary caregiver, 
in our cases the owner, manifested by severe distress when separated from this. 
The first results of analysis that were made on our group of 20 dogs revealed: 
-3 dogs presented behavioral deviation, but others than anxiety separation; 
-1 dog presented anxiety separation syndrome, but was a pregnant female, so we decided 
to make her treatment after it weaned; 
-4 cases presented anxiety separation syndrome and also health problems, so we could 
not start the treatment until they resolve their problems; 
-12 dogs were suffering of anxiety separation syndrome and no healthy problems. 
The results of anamnesis questionnaire emphasize that the most frequently signs are: 
excessively barking, destructions, urinate and defecate in the house and the attempting to escape 















elimination try to escape
other unusual behaviors  




Our fist preoccupation was to make for each of the cases a personalized behaviour 
modification plan. Meanwhile the owner had to fill an evaluation sheet.  
After 6 weeks, based on these sheets and of course on what the owner told us the cases 
were classified in different degrees of severity.  
 




Establisment of severity degree 
 


















Degree of severity 
Destructions 
0 – lack of manifestations 0 0 0 0 0 0 
1 - rarely       
2- moderate manifestation       
3- frequent        
Excessively barking   
0 – lack of manifestations       
1 - rarely     1 1 
2- moderate manifestation    2   
3- frequent  3 3 3    
Urinating and defecating in the house
0 – lack of manifestations 0 0 0 0 0 0 
1 - rarely       
2- moderate manifestation       
3- frequent        
Attempting to escape 
0 – lack of manifestations 0 0 0 0 0 0 
1 - rarely       
2- moderate manifestation       
3- frequent        
Other unusual manifestations 
0 – lack of manifestations       
1 - rarely    1 1 1 
2- moderate manifestation 2 2 2    
3- frequent        
TOTAL 5 5 5 3 2 2 
 
Based on this result we separated the cases in three groups: 
group I - 4 cases with low separation anxiety syndrome, having an score of  1 to 5 points/ week  
and representing 33,33% from all the cases that presented separation anxiety ; 
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group II – 6 dogs with medium separation anxiety syndrome, having a score of 5 to 10 
points and representing 50% from all the cases that presented separation anxiety ; 
group III – 2 dogs with serious separation anxiety syndrome, having a score of 10 to 15 
points and representing 16,66% from all the cases that presented separation anxiety. 
For Group I we recommended to continue the behavioural treatment only. 
The others 2 groups continue with the behavioural treatment in conjunction with drugs 
therapy. As drug therapy we used selective serotonin reuptake inhibitors, fluoxetine, as two 
medicinal products: Reconcile, product by Elli Lilly and Company, chewable tablet formulated 
specifically for dogs for the treatment of canine separation anxiety and Prozac, product also by 
Elli Lilly and Company but for human use. 
 





















Chart 2. Phisiological constants to IMPO case 
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Total Calcium Magnesium Phosphor Cortisol
Blood analysis in case MAX
Befor the treatment After the treatment
 
Chart 5. Blood analysis in case M 
 
Reconcile have different dosage: 8 mg of active substance/tablet, 16 mg of active 
substance/tablet and 32 mg of active substance/tablet. Prozac have 20 mg of active 
substance/tablet. The animals were separated in two lots, 4 cases were treated with Prozac 1 
mg/kg/day as the prospect recommendation, and the other 4 cases were treated with Reconcile 1 
tb/animal/day (in function of the kilograms of the case, different type of dosage). 
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To the first group treated with Prozac- we observed that most of the blood constituents 
suffered modification in the sense of decreasing, except the cortisol, whose value exceeded the 
maximum. For example: Name: Impo Race: Husky, Sex: M, Age: 48 month. 
To the second group treated with Reconcile- we observed that most of the blood 
constituents suffered modification in the sense of decreasing, even the cortisol. 




In all this time we have observed and noted the individual organism constants and we 
took blood for the analyses for each animal. Therapy with Reconcile and Prozac is indicated 
because it gives results in short time and has no side effects. Also it can be said about the two 
medicinal products that they don’t produce major changes in physiological constants or the 
blood, because fluoxetine is a selective inhibitor of serotonin reabsorption, without affecting 
cholinergic receptors or reabsorption of norepinephrine. 
Therapy with Prozac induces the following changes: 
-respiratory rate and heart rate decreases to the physiological lower limit value, while the 
modification of the temperature is hardly visible so we can say that is maintained almost 
constant; -blood level parameters that we have investigated, namely calcium, magnesium and 
phosphorus does not undergo noticeable changes compared to the concentration of cortisol which 
suffer an increase above the maximum allowed. 
Therapy with Reconcile induces the following change: -respiratory rate and heart rate 
decreases to the physiological lower limit value, while the modification of the temperature is 
hardly visible so we can say that is maintained almost constant; -blood level parameters that we 
have investigated, namely calcium, magnesium and phosphorus does not undergo noticeable 
changes compared to the concentration of cortisol which suffer an visible decrease. 
Although the most research results about the Prozac treatment asserts that the cortisol 
level decrease after the treatment, in our study we observed an increase tendency for all the cases 
studied. Increased cortisol should raise a question mark and close attention. Signs of separation 
anxiety that disappear or diminish significantly after Prozac therapy does not mean that the 
animal is out of his state of stress. However, a certain stress level is considered an essential 
stimulus that causes adaptation of the individua to new situations. 
If needed we recommend the medication therapy with smaller doses at the beginning and 
than increased gradually until the wanted results appear, but any medication therapy should start 
only if the behavioural therapy does not give results. Even so for best result medication therapy 
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